Immune abnormalities in aneurysmal subarachnoid haemorrhage patients: Relation to delayed cerebral vasospasm

Scandinavian Journal of Immunology

Volumn 51, Issue 4, 2000, Pages 400-407

  Chrapusta, S J ^a   Gorski A ^b   Mrowiec, T ^b   Grieb, P ^a   Andrychowski, J ^a   Ryba, M S ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; COLLAGEN TYPE 4; DEXAMETHASONE; ELASTIN; FIBRONECTIN;

ADULT; AGED; ARTICLE; BRAIN VASOSPASM; CELL ADHESION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, CD; B-LYMPHOCYTES; CD4-CD8 RATIO; CELL ADHESION; DEXAMETHASONE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MUROMONAB-CD3; SUBARACHNOID HEMORRHAGE; T-LYMPHOCYTES; VASOSPASM, INTRACRANIAL;

EID: 0034003261     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00694.x     Document Type: Article

References (60)

1. Cesarini KG, Hårdemark GH, Persson L. Improved survival after aneurysmal subarachnoid hemorrhage: review of case management during a 12-year period. J Neurosurg 1999;90:664-72.
2. Pasqualin A. Epidemiology and pathophysiology of cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg Sci 1998;42 (Suppl 1):15-21.
3. Sobey CG, Faraci FM. Subarachnoid hemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 1998;25:867-76.
4. Siesjö BK, Siesjö P. Mechanisms of secondary brain injury. Eur J Anaesthesiol 1996;13:247-68.
5. Kubota T, Handa Y, Tsuchida A, Kaneko M, Kobayshi H, Kubota T. The kinetics of lymphocytes subsets and macrophages in subarachnoid space after subarachnoid hemorrhage in rats. Stroke 1993;24:1993-2001.
6. Handa Y, Kabuto M, Kobayashi H, Kawano H, Takeuchi H, Hayashi M. The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery 1991;28:542-9.
7. German JW, Gross CE, Giclas P, Watral W, Bednar MM. Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery 1996;39:141-5.
8. Østergaard JR, Kristensen BØ, Svehag SA, Teisner B, Miletic T. Immune complexes and complement activation following rupture of intracranial saccular aneurysms. J Neurosurg 1987;66:891-7.
9. Lindsberg PJ, Ohman J, Lehto T et al. Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol 1996;40:587-96.
10. Handa Y, Kubota T, Kaneko M et al. Expression of intercellular adhesion molecule-1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats. Acta Neurochir (Wien) 1995;132:92-7.
11. Ryba M, Jarza̧bek-Chorzelska M, Chorzelski T, Pastuszko M. Is vascular angiopathy following aneurysm rupture immunologically mediated? Acta Neurochir (Wien) 1992;117:34-7.
12. 3, and fibrinogen in cerebral arterial walls by immunofluorescence method. Neurol Med Chir (Tokyo) 1984;24:647-54.
13. Polin RS, Bavbek M, Shaffrey ME et al. Detection of soluble E- selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 1998;89:559-67.
14. Weir B. The pathophysiology of cerebral vasospasm. Br J Neurosurg 1995;9:375-90.
15. Panes J, Perry M, Granger DN. Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol 1999;126:537-50.
16. Chyatte D. Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high dose methylprednisolone. Stroke 1989;59:1021-6.
17. Chyatte D, Fode NC, Nichols DA, Sundt TM Jr. Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987;21:157-60.
18. Handa Y, Hayashi M, Takeuchi H, Kobayashi H, Kawano H, Kabuto M. Effect of cyclosporine on the development of cerebral vasospasm in a primate model. Neurosurgery 1991;28:380-6.
19. Ryba M, Pastuszko M, Iwańska K, Bidziński J, Dziewiȩcki C. Cyclosporine A prevents neurological deterioration of patients with SAH - a preliminary report. Acta Neurochir (Wien) 1991;112:25-7.
20. Ryba M, Grieb P, Walski M, Sawicki J, Pastuszko M.2-Chloro-2′- deoxyadenosine prevents angiopathic changes in cerebral arteries in experimental SAH in rabbits. Acta Neurochir (Wien) 1993;122:118-21.
21. Ryba M, Grieb P, Pastuszko M et al. Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine. Acta Neurochir (Wien) 1993;124:61-5.
22. Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 1998;29:1930-6.
23. Oshiro EM, Hoffman PA, Dietsch GN, Watts MC, Pardoll DM, Tamargo RJ. Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats. Stroke 1997;28:2031-7.
24. Thai QA, Oshiro EM, Tamargo RJ. Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers. Stroke 1999;30:140-7.
25. Ono S, Date I, Onoda K et al. Decoy administration of NF-kappaB into the subarachnoid space for cerebral angiopathy. Hum Gene Ther 1998;9:1003-11.
26. Hauzenberger D, Klominek J, Bergström SE, Sundqvist KG. T lymphocyte migration: the influence of interaction via adhesion molecules, the T cell receptor, and cytokines. Crit Rev Immunol 1995;15:285-316.
27. Gorski A, Kupiec-Weglinski JW. Extracellular matrix proteins, regulators of T-cell functions in healthy and diseased individuals. Clin Diagn Lab Immunol 1995;2:646-51.
28. Yanaka K, Camarata PJ, Spellman SR, Skubitz AP, Furcht L, Low WC. Laminin peptide ameliorates brain injury by inhibiting leukocyte accumulation in a rat model of transient focal cerebral ischemia. J Cereb Blood Flow Metab 1997;17:605-11.
29. Ryba M, Grieb P, Pastuszko M et al. Impaired in vitro proliferative response of suppressor lymphocytes in patients with subarachnoid haemorrhage from ruptured intracranial aneurysm. Acta Neurochir (Wien) 1993;122:240-3.
30. Górski A, Castronovo V, Stȩpień-Sopniewska B et al. Depressed immune surveillance against cancer: role of deficient T cell: extracellular matrix interactions. Cell Adhes Commun 1994;2:225-33.
31. Górski A, Piekarczyk J, Skurzak H et al. Abnormalities in T-cell interactions with the extracellular matrix proteins in a patient with Wegener's granulomatosis. Clin Immunol Immunopathol 1993;69:149-54.
32. Martin NA, Doberstein C, Alexander M et al. Posttraumatic cerebral arterial spasm. J Neurotrauma 1995;12:897-901.
33. Romner B, Bellner J, Kongstad P, Sjöholm H. Elevated transcranial Doppler flow velocities after severe head injury: cerebral vasospasm or hyperemia? J Neurosurg 1996;85:90-7.
34. Rabb CH, Tang G, Chin LS, Giannotta SL. A statistical analysis of factors related to symptomatic cerebral vasospasm. Acta Neurochir (Wien) 1994;127:27-31.
35. Østergaard JR, Bruun-Petersen G, Lamm LU. HLA antigens and complement types in patients with intracranial saccular aneurysms. Tissue Antigens 1986;28:176-81.
36. Norrgård Ö, Beckman G, Beckman L, Cedergren B, Fodstad H, Ängquist K-A. Genetic markers in patients with intracranial aneurysms. Hum Hered 1987;37:255-9.
37. Ryba M, Grieb P, Podobińska I, Iwańska K, Pastuszko M, Górski A. HLA antigens and intracranial aneurysms. Acta Neurochir (Wien) 1992;116:1-5.
38. Sakaguchi J, Takeshita M, Kagawa M, Izawa M, Takakura K. HLA- type of cerebral vasospasm patients after aneurysmal subarachnoid hemorrhage. Neurosurg Rev 1994;17:67-71.
39. Doczi T. The pathogenetic and prognostic significance of blood- brain barrier damage at the acute stage of aneurysmal subarachnoid hemorrhage. Clinical and experimental studies. Acta Neurochir (Wien) 1985;77:110-32.
40. Wekerle H, Linington C, Lassmann H, Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci 1986;9:271-7.
41. Sengupta RP, McAllister VL. Subarachnoid Haemorrhage. Berlin:- Springer-Verlag, 1986.
42. Benedict CR, Loach AB. Sympathetic nervous system activity in patients with subarachnoid hemorrhage. Stroke 1978;9:237-44.
43. Minegishi A, Ishizaki T, Yoshida Y, Ahagon A, Shibata N, Kobayashi H. Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage. Clinical implications. Arch Neurol 1987;44:423-8.
44. Mills PJ, Ziegler MG, Rehman J, Maisel AS. Catecholamines, catecholamine receptors, cell adhesion molecules, and acute stressor-related changes in cellular immunity. Adv Pharmacol 1998;42:587-90.
45. Loach AB, Benedict CR. Plasma catecholamine concentrations associated with cerebral vasospasm. J Neurol Sci 1980;45:261-71.
46. Bergquist J, Josefsson E, Tarkowski A, Ekman R, Ewing A. Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis. Electrophoresis 1997;18:1760-6.
47. Musso NR, Brenci S, Setti M, Indiveri F, Lotti G. Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes. J Clin Endocrinol Metab 1996;81:3553-7.
48. Weller I, Lockwood CM, Chandra RK. Secondary immunodeficiency. In: Roitt I, Brostoff J, Male D, eds. Immunology, 5th edn. London: Mosby, 1998:293-300.
49. Peterszegi G, Texier S, Robert L. Human helper and memory lymphocytes exhibit an inducible elastin-laminin receptor. Int Arch Allergy Immunol 1997;114:218-23.
50. Peterszegi G, Texier S, Robert L. Cell death by overload of the elastin-laminin receptor on human activated lymphocytes: protection by lactose and melibiose. Eur J Clin Invest 1999;29:166-72.
51. Pitzalis C, Pipitone N, Bajocchi G et al. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol 1997;158:5007-16.
52. Farsky SP, Sannomiya P, Garcia-Leme J. Secreted glucocorticoids regulate leukocyte-endothelial interactions in inflammation. A direct vital microscopic study. J Leukoc Biol 1995;57:379-86.
53. van Lier RAW, Brouwer M, Rebel VI, van Noessel CJM, Aarden LA. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes. Immunology 1989;68:45-50.
54. Young JW, Steinman RM. Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells. Cell Immunol 1988;111:167-82.
55. + T cells and macrophages. Scand J Immunol 1993;37:111-15.
56. Hinek A. Nature and the multiple functions of the 67-kD elastin/laminin binding protein. Cell Adhes Commun 1994;2:185-93.
57. Górski A, Orłowska A, Nowaczyk M, Kasprzycka M, Rancewicz ZP, Paczek L. Statins inhibit T-cell interactions with elastin. Transplant Proc 1999;31:828-9.
58. Zhang ZG, Chopp M, Tang WX, Jiang N, Zhang RL. Postischemic treatment (2-4h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2h) focal cerebral ischemia in the rat. Brain Res 1995;698:79-85.
59. Wilckens T, De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 1997;18:418-24.
60. Wilckens T. Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction. Trends Pharmacol Sci 1995;16:193-7.